InvestorsObserver
×
News Home

Can Crinetics Pharmaceuticals Inc (CRNX) Stock Rise to the Top of Healthcare Sector Thursday?

Thursday, December 07, 2023 12:32 PM | InvestorsObserver Analysts

Mentioned in this article

Can Crinetics Pharmaceuticals Inc (CRNX) Stock Rise to the Top of Healthcare Sector Thursday?

Crinetics Pharmaceuticals Inc (CRNX) is around the top of the Healthcare sector according to InvestorsObserver. CRNX received an overall rating of 100, which means that it scores higher than 100% of stocks. Additionally, Crinetics Pharmaceuticals Inc scored a 97 in the Healthcare sector, ranking it higher than 97% of stocks in that sector.

Overall Score - 100
CRNX has an Overall Score of 100. Find out what this means to you and get the rest of the rankings on CRNX!

What do These Ratings Mean?

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. *Investors Observer* allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 100 would rank higher than 100 percent of all stocks. Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With Crinetics Pharmaceuticals Inc Stock Today?

Crinetics Pharmaceuticals Inc (CRNX) stock has fallen -0.15% while the S&P 500 is higher by 0.78% as of 12:21 PM on Thursday, Dec 7. CRNX is lower by -$0.05 from the previous closing price of $33.23 on volume of 121,243 shares. Over the past year the S&P 500 is up 16.55% while CRNX is higher by 87.03%. CRNX lost -$3.64 per share the over the last 12 months. Click Here to get the full Stock Report for Crinetics Pharmaceuticals Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App